ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Survival"

  • 2018 American Transplant Congress

    A Propensity Matched Survival Analysis: Do Simultaneous Liver-Lung Transplant Recipients Need a Liver?

    K. Freischlag,1 B. Ezekian,2 P. Schroder,2 M. Mulvihill,2 S. Knechtle.2

    1School of Medicine, Duke University, Durham, NC; 2Surgery, Duke University, Durham, NC.

    Objective: There is debate whether simultaneous lung-liver transplant (LLT) long-term outcomes warrant allocation of two organs to a single recipient. We hypothesized that LLT recipients…
  • 2018 American Transplant Congress

    Accepting a DCD Liver May Improve Patient Survival Compared to Waiting for a Non-DCD Liver

    A. Wey,1 N. Salkowski,1 J. Lake,2 W. Kim,3 B. Kasiske,1 A. Israni,1 J. Snyder.1

    1Scientific Registry of Transplant Recipients, Minneapolis; 2Univ of Minnesota, Minneapolis; 3Stanford University, Palo Alto.

    Only ~50% of liver candidates undergo deceased donor transplant; 17% die on the waiting list and 20% are removed from the list as too sick…
  • 2018 American Transplant Congress

    Relation between Seroprevalence of Cytomegalovirus and Graft Survival in Japanese Kidney Transplant Recipients: The Japan Academic Consortium of Kidney Transplantation Study

    K. Miyake,1,2 M. Okumi,1 K. Unagami,3 Y. Kakuta,1 H. Shirakawa,4 K. Omoto,5 H. Ishida,1 K. Tanabe.1

    1Urology, Tokyo Women's Medical University, Tokyo, Japan; 2Kidney Transplantation, Shonan Kamakura General Hospital, Kamakura, Japan; 3Nephrology, Tokyo Women's Medical University, Tokyo, Japan; 4Urology, Okubo Hospital, Tokyo, Japan; 5Urology, Toda Chuo General Hospital, Saitama, Japan.

    BackgroundCytomegalovirus (CMV) infection is one of major causes of morbidity in kidney transplant recipients (KTRs). However, the current prevalence of CMV in KTRs and the…
  • 2018 American Transplant Congress

    Effect of Ethnicity on Recipient Characteristics, Kidney Transplant Provision and Outcomes in a High-Volume National Health Service Hospital

    E. Favi,1 C. Puliatti,2 M. Ferraresso,1 R. Cacciola.2

    1Kidney Transplant, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy; 2Kidney Transplant, Barts Health NHS Trust, The Royal London Hospital, London, United Kingdom.

    Background. Several reports have demonstrated that outcomes of kidney transplantation (KTx) can be influenced by recipient's ethnicity and social status. However, available data mostly refer…
  • 2018 American Transplant Congress

    The Influence of Rabbit Antithymocyte Globulin (rATG) Dose on the Incidence of CMV Infection in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis. A Propensity Score Matched Cohort Analysis

    M. Ivani de Paula,1,2 S. Bae,1 J. Garonzik-Wang,1 C. Felipe,2 M. Cristelli,2 A. Massie,1,3 J. Medina-Pestana,2 D. Segev,1,3 H. Tedesco Silva J�nior.2

    1Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD; 2Department of Nephrology, Hospital do Rim, Universidade Federal de Sao Paulo, Sao Paulo, Brazil; 3Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, Brazil.

    rATG has become the agent of choice for induction therapy in sensitized patients and those receiving expanded criteria donors (ECD) allografts. However, the optimal dose…
  • 2018 American Transplant Congress

    Pre-Transplant versus De Novo Donor Specific Antibodies: Differences in Clinical Outcomes and Antibody Mediated Rejection

    M. Ajaimy, N. Hayde, A. Colovai, E. Akalin.

    Montefiore-Einstein Transplant Center, Montefiore-Einstein Transplant Center, Bronx.

    Background: Antibody mediated rejection (ABMR) can occur through pre-transplant(tx) vs. de novo donor specific antibodies (DSA). Clinical outcomes, allograft injury and dynamics of DSAs have…
  • 2018 American Transplant Congress

    Survival in Deceased Donor Kidney Transplant by Kidney Donor Profile Index versus Intensive Home Hemodialysis

    A. Nishio-Lucar,1 G. Lyons,2 S. Bose,3 J. Ma,2 K. Awuah,3 R. Lockridge.3

    1Internal Medicine, University of Virginia, Charlottesville, VA; 2Public Health Science, University of Virginia, Charlottesville, VA; 3Lynchburg Nephrology Physicians, Lynchburg, VA.

    In an era of donor scarcity, high Kidney Donor Profile Index (KDPI) >85% organs can serve as a pathway to timely transplant. We previously reported…
  • 2018 American Transplant Congress

    Use of Proton-Pump Inhibitors is Associated with Lower Magnesium and Iron Status and Excess Mortality in Renal Transplant Recipients

    A. Gomes-Neto,1 R. Douwes,1 M. Eisenga,1 S. Berger,1 R. Gans,1 E. Berg,1 G. Navis,1 H. Blokzijl,2 S. Bakker.1

    1Nephrology, UMCG, Groningen, Netherlands; 2Gastroenterology and Hepatology, UMCG, Groningen, Netherlands.

    BackgroundProton-pump inhibitor (PPI) use is common in renal transplant recipients (RTR). However, PPI use may induce micronutrient deficiencies and has been associated with increased mortality…
  • 2018 American Transplant Congress

    Major Adverse Cardiovascular Events Following Simultaneous Pancreas and Kidney Transplantation. A Study of the United Kingdom Transplant Registry

    P. Yiannoullou,1,2 A. Summers,1,2 C. Fullwood,2 Z. Moinuddin,1,2 I. Shapey,1,2 H. Khambalia,1,2 T. Augustine,1,2 M. Rutter,1,2 D. van Dellen.1,2

    1Transplantation, Manchester University NHS Foundation Trust, Manchester, United Kingdom; 2University of Manchester, Manchester, United Kingdom.

    BackgroundPatients with type 1 diabetes mellitus (T1DM) and end-stage renal disease (ESRD) suffer increased cardiovascular morbidity and mortality. Simultaneous pancreas and kidney transplantation (SPKT) improves…
  • 2018 American Transplant Congress

    Neutrophil-Lymphocyte Ratio(NLR) is Significantly Decreased in Kidney Transplant Patients: Is NLR a Novel Predictor of Cardiovascular Disease in Kidney Transplant Patients?

    H. Shirakawa,1 J. Hasegawa,2 A. Ishiwatari,2 M. Kono,2 S. Wakai.2

    1Urology, Ohkubo Hospital, Shinjuku, Tokyo, Japan; 2Nephrology, Ohkubo Hospital, Shinjuku, Tokyo, Japan.

    【Background】The neutrophil-to-lymphocyte ratio (NLR) is a novel simple biomarker of in inflammation. It has emerged as a predictor of poor prognosis in cancer and cardiovascular…
  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 66
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences